KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $2.95 Friday, 26th Apr 2024 CLLS stock ended at $2.51. This is 0.627% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.62% from a day low at $2.35 to a day high of $2.51.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Dec 06, 2021 $8.03 $8.24 $7.80 $8.05 170 288
Dec 03, 2021 $8.52 $8.67 $8.00 $8.24 264 201
Dec 02, 2021 $8.55 $8.76 $8.29 $8.61 155 710
Dec 01, 2021 $9.27 $9.48 $8.76 $8.80 230 931
Nov 30, 2021 $8.75 $8.99 $8.15 $8.62 348 668
Nov 29, 2021 $8.89 $9.08 $8.30 $8.37 148 177
Nov 26, 2021 $8.58 $8.79 $8.53 $8.69 81 713
Nov 24, 2021 $8.47 $8.81 $8.30 $8.72 115 121
Nov 23, 2021 $8.48 $8.51 $8.17 $8.34 240 224
Nov 22, 2021 $8.82 $8.82 $8.35 $8.36 344 157
Nov 19, 2021 $9.08 $9.10 $8.80 $8.91 201 985
Nov 18, 2021 $9.45 $9.47 $8.96 $9.10 177 350
Nov 17, 2021 $9.69 $9.81 $9.16 $9.44 214 899
Nov 16, 2021 $9.88 $9.98 $9.72 $9.76 128 770
Nov 15, 2021 $10.56 $10.56 $9.92 $9.98 124 508
Nov 12, 2021 $10.70 $10.70 $10.17 $10.56 159 407
Nov 11, 2021 $10.75 $10.75 $10.26 $10.34 181 986
Nov 10, 2021 $11.05 $11.22 $10.60 $10.69 139 623
Nov 09, 2021 $11.42 $11.56 $11.10 $11.21 240 928
Nov 08, 2021 $11.89 $12.01 $11.33 $11.67 394 258
Nov 05, 2021 $11.60 $12.49 $11.04 $12.23 195 395
Nov 04, 2021 $12.56 $12.73 $12.03 $12.28 255 039
Nov 03, 2021 $12.13 $13.08 $12.03 $12.84 216 493
Nov 02, 2021 $12.39 $12.80 $12.14 $12.61 213 310
Nov 01, 2021 $10.63 $11.91 $10.57 $11.78 280 715
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT